Intuitive Surgical, Inc. $ISRG Position Decreased by Profund Advisors LLC

Profund Advisors LLC lessened its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 6.9% during the third quarter, Holdings Channel.com reports. The firm owned 26,617 shares of the medical equipment provider’s stock after selling 1,960 shares during the quarter. Profund Advisors LLC’s holdings in Intuitive Surgical were worth $10,823,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. Main Street Group LTD purchased a new stake in Intuitive Surgical during the 1st quarter valued at about $30,000. North Point Portfolio Managers Corp OH purchased a new stake in shares of Intuitive Surgical in the 3rd quarter worth $27,000. John Boyer Inc. purchased a new position in Intuitive Surgical in the third quarter valued at about $27,000. Compass Wealth Management LLC acquired a new stake in Intuitive Surgical in the third quarter worth about $29,000. Finally, Evergreen Advisors LLC acquired a new position in Intuitive Surgical in the 1st quarter worth approximately $35,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Trading Down 3.7%

Shares of NASDAQ ISRG opened at $432.01 on Friday. The company has a fifty day moving average price of $401.54 and a 200 day moving average price of $434.05. The firm has a market cap of $149.75 billion, a PE ratio of 52.24, a PEG ratio of 2.98 and a beta of 1.46. Intuitive Surgical, Inc. has a 1-year low of $328.57 and a 1-year high of $603.88.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 20th. The medical equipment provider reported $3.00 EPS for the quarter, beating the consensus estimate of $2.65 by $0.35. Intuitive Surgical had a net margin of 25.54% and a return on equity of 18.17%. The firm had revenue of $3.05 billion for the quarter, compared to the consensus estimate of $2.91 billion. During the same period in the previous year, the company earned $2.40 earnings per share. The company’s quarterly revenue was up 21.7% on a year-over-year basis. Equities research analysts forecast that Intuitive Surgical, Inc. will post 9.37 EPS for the current year.

Insiders Place Their Bets

In related news, Director Gary Guthart sold 20,095 shares of Intuitive Surgical stock in a transaction on Friday, October 23rd. The shares were sold at an average price of $451.61, for a total value of $9,075,102.95. Following the completion of the sale, the director owned 1,204,530 shares of the company’s stock, valued at approximately $543,977,793.30. This trade represents a 1.64% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, VP Fredrik Widman sold 4,047 shares of the business’s stock in a transaction on Friday, October 23rd. The stock was sold at an average price of $453.21, for a total value of $1,834,140.87. Following the completion of the transaction, the vice president directly owned 1,026 shares in the company, valued at approximately $464,993.46. This represents a 79.78% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last three months, insiders sold 38,778 shares of company stock valued at $16,814,967. 0.60% of the stock is currently owned by corporate insiders.

Wall Street Analyst Weigh In

Several analysts recently issued reports on the stock. BTIG Research reaffirmed a “buy” rating and set a $454.00 price objective on shares of Intuitive Surgical in a research note on Wednesday, October 21st. Leerink Partners set a $503.00 price objective on shares of Intuitive Surgical and gave the stock an “outperform” rating in a research report on Wednesday, October 21st. Mizuho decreased their price objective on shares of Intuitive Surgical from $415.00 to $400.00 and set a “neutral” rating on the stock in a research report on Wednesday, October 21st. KeyCorp reaffirmed an “overweight” rating on shares of Intuitive Surgical in a research note on Wednesday, August 12th. Finally, Evercore set a $430.00 price target on Intuitive Surgical in a research note on Monday, July 6th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-three have assigned a Buy rating, five have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Intuitive Surgical has a consensus rating of “Moderate Buy” and a consensus price target of $493.54.

About Intuitive Surgical

Intuitive Surgical, Inc develops and manufactures robotic-assisted systems and related technologies for minimally invasive surgery. Its products are designed to help surgeons perform procedures through small incisions while providing enhanced visualization, precision and control. The company’s primary platform is the da Vinci Surgical System, which is used across a range of specialties, including urology, gynecology, general surgery, cardiothoracic surgery and other procedures.

The company also offers the Ion endoluminal system, which is designed to support minimally invasive lung biopsy procedures.